Citation Impact
Citing Papers
Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis
2010 Standout
Tumor imaging by means of proteolytic activation of cell-penetrating peptides
2004 StandoutNobel
The Scurfy mutation of FoxP3 in the thymus stroma leads to defective thymopoiesis
2005
Synovial membrane expression of matrix metalloproteinases and tissue inhibitor 1 in juvenile idiopathic arthritides.
2002
The discordance between clinical and radiographic knee osteoarthritis: A systematic search and summary of the literature
2008 Standout
Novel IL10 gene family associations with systemic juvenile idiopathic arthritis
2006
From stress to inflammation and major depressive disorder: A social signal transduction theory of depression.
2014 Standout
Needs and preferences regarding health care delivery as perceived by patients with systemic sclerosis
2011 Standout
Clinical assessment of the osteoarthritis patient
2001
Heterozygous Mutations in TREX1 Cause Familial Chilblain Lupus and Dominant Aicardi-Goutières Syndrome
2007 StandoutNobel
Classification criteria for psoriatic arthritis: Development of new criteria from a large international study
2006 Standout
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel
2000 Standout
Haemoglobinopathies and the rheumatologist
2016
Small-Vessel Vasculitis
1997 Standout
Sjögren's syndrome
2005 Standout
Role of platelet-derived growth factors in physiology and medicine
2008 Standout
Whole-Genome Screening in Ankylosing Spondylitis: Evidence of Non-MHC Genetic-Susceptibility Loci
2001
Monocytes of Patients with Systemic Sclerosis (Scleroderma) Spontaneously Release In Vitro Increased Amounts of Superoxide Anion
1999
PD-1 deficiency results in the development of fatal myocarditis in MRL mice
2010 StandoutNobel
Juvenile idiopathic arthritis
2007 Standout
Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement
2005
Research diagnostic criteria for temporomandibular disorders: a systematic review of axis I epidemiologic findings
2011 Standout
Inflamm‐aging: An Evolutionary Perspective on Immunosenescence
2000 Standout
Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome)
2010
Psoriatic arthritis: A unified concept twenty years on
1999
On the origin of the catalytic power of carboxypeptidase A and other metalloenzymes
2009 StandoutNobel
Conventional treatments for ankylosing spondylitis
2002
Chromosome 22q11.2 Deletion Syndrome (DiGeorge Syndrome/Velocardiofacial Syndrome)
2010
Benefits and Risks of Minocycline in Rheumatoid Arthritis
2000
Methotrexate in Resistant Juvenile Rheumatoid Arthritis
1992
Sulfasalazine in the treatment of juvenile chronic arthritis: A randomized, double-blind, placebo-controlled, multicenter study
1998
Scleroderma
2009 Standout
IL-6 as a keystone cytokine in health and disease
2015 Standout
The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.
1998 Standout
Stimulatory Autoantibodies to the PDGF Receptor in Systemic Sclerosis
2006
Foxp3+CD25+CD4+ natural regulatory T cells in dominant self‐tolerance and autoimmune disease
2006 StandoutNobel
Cree encephalitis is allelic with Aicardi-Goutiéres syndrome: implications for the pathogenesis of disorders of interferon alpha metabolism
2003
Cleft lip and palate: understanding genetic and environmental influences
2011 Standout
Interstitial Lung Disease in Systemic Sclerosis
2008 Standout
Are picro-dye reactions for collagens quantitative?
1988
IL-6 in Inflammation, Immunity, and Disease
2014 Standout
Signalling pathways of the TNF superfamily: a double-edged sword
2003 Standout
Matrix metalloproteinase inhibitors in rheumatic diseases
2001
Ankylosing spondylitis
2007 Standout
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Immunization in rheumatic diseases of childhood: an audit of the clinical practice of British Paediatric Rheumatology Group members and a review of the evidence
2002
Prevalence of Sjögren’s syndrome in a closed rural community
1997
Systemic sclerosis: a prototypic multisystem fibrotic disorder
2007 Standout
Systemic JIA: new developments in the understanding of the pathophysiology and therapy
2009
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Sickle-cell disease
2010 Standout
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part I
2007 Standout
The clinical, immunological, and molecular spectrum of chromosome 22q11.2 deletion syndrome and DiGeorge syndrome
2004
The use of methotrexate in childhood rheumatic diseases
1998
Actual status of antiinterleukin-1 therapies in rheumatic diseases
2010
Primary systemic vasculitis
1997
The epidemiology of chronic generalized musculoskeletal pain
2003
The Diverse Clinical Features of Chromosome 22q11.2 Deletion Syndrome (DiGeorge Syndrome)
2013
The juvenile-onset spondyloarthritides
2002
Chondroitin sulfate and joint disease
1998
Functional Specialization of Interleukin-17 Family Members
2011 Standout
Normal and Pathologic Concentrations of Uremic Toxins
2012 Standout
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part II
2007 Standout
Mortality and prognostic factors in Spanish patients with systemic sclerosis
2002
Iloprost suppresses connective tissue growth factor production in fibroblasts and in the skin of scleroderma patients
2001
Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab
2002
Prevalence and incidence of juvenile idiopathic arthritis: A systematic review
2013 Standout
Anti–tumor necrosis factor α therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: A followup report of tolerability and efficacy
2003
Microneedles for drug and vaccine delivery
2012 Standout
Tolerability and pharmacokinetics of the collagenase‐selective inhibitor Trocade™ in patients with rheumatoid arthritis
2001
Metabolism of complement factor D in renal failure
1988
Current management of juvenile idiopathic arthritis
2006
Measuring educational needs among patients with rheumatoid arthritis using the Dutch version of the Educational Needs Assessment Tool (DENAT)
2009
Cardiovascular morbidity in psoriatic arthritis
2008
22q11.2 deletion syndrome
2015 Standout
Polymyositis and dermatomyositis
2003 Standout
Muscle as an Endocrine Organ: Focus on Muscle-Derived Interleukin-6
2008 Standout
Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity
2004
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
Clinical features and outcomes of juvenile dermatomyositis and other childhood onset myositis syndromes
2002
Needle-free and microneedle drug delivery in children: A case for disease-modifying antirheumatic drugs (DMARDs)
2011
Carbohydrate sulfotransferases: mediators of extracellular communication
1999 StandoutNobel
The challenge of diagnosis and classification in early ankylosing spondylitis: Do we need new criteria?
2005 Standout
Global epidemiology of gout: prevalence, incidence and risk factors
2015 Standout
TGF‐β signaling and the fibrotic response
2004 Standout
VASCULITIS IN CHILDREN AND ADOLESCENTS
1995
Worldwide prevalence of juvenile arthritis why does it vary so much?
2002
Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system.
1991 Standout
BAFF and APRIL: A Tutorial on B Cell Survival
2003
A systematic review of effectiveness and economic evaluation of new drug treatments for juvenile idiopathic arthritis: etanercept
2002
Minocycline: far beyond an antibiotic
2013 Standout
Histone H3 lysine 9 di-methylation as an epigenetic signature of the interferon response
2012 StandoutNobel
Arthritis and uveitis in children
2003
V Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose
2013 Standout
Clinical and molecular genetics of Stickler syndrome
1999
Systemic lupus erythematosus
2010
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Epidemiology of rheumatoid arthritis, juvenile idiopathic arthritis and gout in two regions of the Czech Republic in a descriptive population-based survey in 2002-2003.
2007
Hematological Problems in Pediatric Intensive Care
2013 Standout
Works of P Woo being referenced
Amyloidosis in juvenile chronic arthritis: a morbidity and mortality study.
1993
Pediatric rheumatology in the United Kingdom: data from the British Pediatric Rheumatology Group National Diagnostic Register.
1996
Oxford Textbook of Rheumatology
1993
2.2 A phase II trial with canakinumab, a new IL-1beta blocking monoclonal antibody (ACZ885), to evaluate preliminary dosing, safety and efficacy profile in children with systemic Juvenile Idiopathic arthritis (sJIA)
2008
School attendance and juvenile chronic arthritis
1997
A multicentre pilot study of sulphasalazine in juvenile chronic arthritis.
1991
Simultaneous turnover of normal and dysfunctional C1 inhibitor as a probe of in vivo activation of C1 and contact activatable proteases.
1985
Are parents' views about their child's treatment for juvenile idiopathic arthritis (JIA) related to evaluations of their child's quality of life (QoL)? – SPARKS CHARM study
2008
The effects of intravenous pulse methylprednisolone on immunological and inflammatory processes in ankylosing spondylitis.
1983
Polyarteritis nodosa associated with streptococcus.
1993
A LIGHT-FAST MODIFICATION OF LILLIE'S ALLOCHROME STAIN. PERIODIC ACID-SHIFF-PICRO-SIRIUS SUPRA BLUE GL.
1964
Low-dose methotrexate in systemic onset juvenile chronic arthritis.
1990
Juvenile idiopathic polyarticular arthritis and IgA deficiency in the 22q11 deletion syndrome.
2001